How To Streamline, Simplify, and Expand Your Compassionate Use Program

NORTHAMPTON, MA / ACCESSWIRE / September 23, 2022 / CyberGrants

For eligible patients, compassionate use can be an effective and potentially life-saving program. Unfortunately, implementation is often easier said than done. Such programs require policies and governance structures, strategic partnerships, and an easy-to-use request system. Fortunately, CyberGrants can help here!

Expanded Access (aka Compassionate Use) is an important program that provides patients struggling with life-threatening illnesses with early access to medications not approved for use in their jurisdiction. For example, a cancer patient with no treatment options who cannot be enrolled in a clinical trial may have access to investigational drugs that are not otherwise widely available to patients.

Not only does compassionate use open up treatment options for some patients, but it has also benefited regulatory approval processes by providing valuable real-world data on efficacy and safety. By relieving patients in the direst of circumstances and enabling the development of revolutionary treatments, there is no doubt that Expanded Access programs can be beneficial to the entire healthcare ecosystem.

While these programs offer myriad benefits, they are subject to global regulations and require careful monitoring and strict compliance. In addition, access requests often require a fast turnaround time. The decision to treat a patient with end-stage disease must be made within days, if not hours. As a result, oversight must be carefully balanced against speed.

A commitment to compassionate use means having policies, end-to-end processes, and systems in place to handle requests quickly, fairly, and efficiently. This is where we come in!

Learn how CyberGrants can facilitate your compassionate use program

At CyberGrants, we’ve been helping our clients track, approve, and monitor grant requests through our grants management platform for over 20 years. As a result, it seemed a natural progression to expand our offering and help pharmaceutical and life science companies manage extended access requests. Our system allows healthcare providers to submit drug requests, along with relevant test results and supporting documentation, in the format best suited to enable a speedy review process.

When a request is submitted, CyberGrants automatically assigns it to the appropriate approvers based on the drug requested, location, and a variety of other factors, eliminating the need to manually route it. For a request with a short response window, manually routing and managing can waste important time a patient may not have. We will forward the request to the necessary stakeholders for timely review and approval. In some cases, the drug can even be shipped the same day! If more information is needed, additional documents can be quickly submitted through our system, eliminating costly back and forth with healthcare providers. But that’s not all! Each step of this process is tracked through CyberGrants and can later be made available for compliance and audit purposes.

The future of compassionate use

The CyberGrants team is passionate about finding ways to use our technology to improve lives and create maximum social impact. While this is just one of many ways to achieve this goal, it has an immediate, tangible impact on people battling life-threatening illnesses. We are proud that we can help make this process faster and easier.

While we’re proud of this work, we know we can always do more. We’re constantly looking for ways to further streamline the process, including facilitating backorder requests in a way that simplifies submissions, expedites approvals, and allows for follow-up to reflect a complete record from the original request through all backorders. We look forward to working closely with the pharmaceutical industry to make our platform even better and improve the lives of patients everywhere.

Ready to harness the power of an advanced access program? Get personalized guidance with CyberGrants today.

Check out the original content here.

CyberGrants, Friday, September 23, 2022, Image of press release

Check out additional multimedia content and more ESG storytelling from CyberGrants at

Contact information:
Narrator: CyberGrants
E-mail: [email protected]

SOURCE: CyberGrants

Leave a Reply

Your email address will not be published. Required fields are marked *